Industry researchers estimate that while about 12% of United States citizens have used a GLP-1 medication for weight loss, 54% of adults who have taken GLP-1s say it was difficult to afford, and 53% say it was still too expensive even if they received insurance coverage for the medication
Lancet Title: Tirzepatide Once Weekly for the Treatment of Obesity in People With Type 2 Diabetes (Surmount-2): A Double-Blind, Randomised, Multicentre, Placebo-Controlled, Phase 3 Trial
Read our deep-dive guide: Pepcid vs Prilosec: The Difference & The GLP-1 "PPI Trap" Your Pharmacy Shopping List: Famotidine: (Generic Pepcid AC) The ideal "Goldilocks" solution for GLP-1 users
Omeprazole: (Generic Prilosec) A powerful Proton Pump Inhibitor (PPI) that should be used with caution
it changes outcomes
For more information, please visit noom.com, subscribe to our blog, or follow us on Twitter and LinkedIn